These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 7839671
1. [Two forms of aldose reductase in erythrocytes from patients with insulin-dependent diabetes mellitus]. Shono NI, Rabinovich SE, Platonova LV, Diuzheva TG. Vopr Med Khim; 1994; 40(5):45-8. PubMed ID: 7839671 [Abstract] [Full Text] [Related]
2. Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. Song HP, Han XY, He Y, Kang TB, Wu HW. Chin Med J (Engl); 1991 Oct; 104(10):818-24. PubMed ID: 1661222 [Abstract] [Full Text] [Related]
3. Activation of aldose reductase by nonenzymatic glycosylation. Srivastava SK, Ansari NH, Bhatnagar A, Hair G, Liu S, Das B. Prog Clin Biol Res; 1989 Oct; 304():171-84. PubMed ID: 2506561 [Abstract] [Full Text] [Related]
4. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties. Srivastava SK, Ansari NH, Hair GA, Jaspan J, Rao MB, Das B. Biochim Biophys Acta; 1986 Mar 28; 870(2):302-11. PubMed ID: 3082363 [Abstract] [Full Text] [Related]
9. Oxidized aldose reductase: in vivo factor not in vitro artifact. Grimshaw CE, Lai CJ. Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700 [Abstract] [Full Text] [Related]
10. No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients. Hamada Y, Hammon K, Raskin P. J Diabetes Complications; 1992 Mar 01; 6(2):111-5. PubMed ID: 1611134 [Abstract] [Full Text] [Related]
11. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities. Rees-Milton KJ, Jia Z, Green NC, Bhatia M, El-Kabbani O, Flynn TG. Arch Biochem Biophys; 1998 Jul 15; 355(2):137-44. PubMed ID: 9675019 [Abstract] [Full Text] [Related]
12. Increased erythrocyte aldose reductase activity in type 1 diabetic patients. Hamada Y, Kito R, Raskin P. Diabet Med; 1991 Apr 15; 8(3):226-31. PubMed ID: 1828737 [Abstract] [Full Text] [Related]
14. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus. Demaine A, Cross D, Millward A. Invest Ophthalmol Vis Sci; 2000 Dec 15; 41(13):4064-8. PubMed ID: 11095596 [Abstract] [Full Text] [Related]
17. Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus. Hamada Y, Hammon K, Raskin P. J Diabetes Complications; 1992 Dec 15; 6(4):242-6. PubMed ID: 1482782 [Abstract] [Full Text] [Related]
19. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes. van Griensven JM, Jusko WJ, Lemkes HH, Kroon R, Verhorst CJ, Chiang ST, Cohen AF. Clin Pharmacol Ther; 1995 Dec 15; 58(6):631-40. PubMed ID: 8529328 [Abstract] [Full Text] [Related]
20. [Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications]. Chistiakov DA, Turakulov RI, Girashko NM, Demurov LM, Rachiba IuM, Kondrat'ev IaIu, Milen'kaia TM, Shestakova MV, Dedov II, Nosikov VV. Mol Biol (Mosk); 1997 Dec 15; 31(5):778-83. PubMed ID: 9454059 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]